JP2012501296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012501296A5 JP2012501296A5 JP2011508745A JP2011508745A JP2012501296A5 JP 2012501296 A5 JP2012501296 A5 JP 2012501296A5 JP 2011508745 A JP2011508745 A JP 2011508745A JP 2011508745 A JP2011508745 A JP 2011508745A JP 2012501296 A5 JP2012501296 A5 JP 2012501296A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- stress
- fluoropyridin
- gastritis
- ulcers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- JDCBSVKVFVIKHL-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(4-methylpyridin-2-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound FC=1C(CNC)=CN(S(=O)(=O)C=2N=CC=C(C)C=2)C=1C1=CC=CN=C1F JDCBSVKVFVIKHL-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 7
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 6
- 208000008469 Peptic Ulcer Diseases 0.000 claims 4
- 208000025865 Ulcer Diseases 0.000 claims 4
- 208000011906 peptic ulcer disease Diseases 0.000 claims 4
- 230000035882 stress Effects 0.000 claims 4
- 231100000397 ulcer Toxicity 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 208000007882 Gastritis Diseases 0.000 claims 2
- 206010017866 Gastritis haemorrhagic Diseases 0.000 claims 2
- 206010020601 Hyperchlorhydria Diseases 0.000 claims 2
- 206010042220 Stress ulcer Diseases 0.000 claims 2
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 claims 2
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 claims 2
- 230000037328 acute stress Effects 0.000 claims 2
- 208000000718 duodenal ulcer Diseases 0.000 claims 2
- 210000003238 esophagus Anatomy 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 claims 2
- 208000017215 gastric mucosa-associated lymphoid tissue lymphoma Diseases 0.000 claims 2
- 201000000052 gastrinoma Diseases 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- 208000000689 peptic esophagitis Diseases 0.000 claims 2
- 230000002980 postoperative effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- DPRWORPFTHSTIE-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(4-methoxypyridin-2-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound FC=1C(CNC)=CN(S(=O)(=O)C=2N=CC=C(OC)C=2)C=1C1=CC=CN=C1F DPRWORPFTHSTIE-UHFFFAOYSA-N 0.000 claims 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000009858 acid secretion Effects 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 230000002860 competitive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940126535 potassium competitive acid blocker Drugs 0.000 claims 1
- 229910001414 potassium ion Inorganic materials 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- -1 2-fluoropyridin-3-yl Chemical group 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000001548 androgenic effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- WNFZZBXZGQNHQE-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(4-methylpyridin-2-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine;hydrochloride Chemical compound Cl.FC=1C(CNC)=CN(S(=O)(=O)C=2N=CC=C(C)C=2)C=1C1=CC=CN=C1F WNFZZBXZGQNHQE-UHFFFAOYSA-N 0.000 description 1
- PKVQYVUTTKAEBW-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(5-fluoropyridin-3-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound FC=1C(CNC)=CN(S(=O)(=O)C=2C=C(F)C=NC=2)C=1C1=CC=CN=C1F PKVQYVUTTKAEBW-UHFFFAOYSA-N 0.000 description 1
- ASDZKCNDAHKXPO-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(5-fluoropyridin-3-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine;hydrochloride Chemical compound Cl.FC=1C(CNC)=CN(S(=O)(=O)C=2C=C(F)C=NC=2)C=1C1=CC=CN=C1F ASDZKCNDAHKXPO-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- FIDJLNBSSLXRLL-UHFFFAOYSA-N butanedioic acid;1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(5-fluoropyridin-3-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound OC(=O)CCC(O)=O.FC=1C(CNC)=CN(S(=O)(=O)C=2C=C(F)C=NC=2)C=1C1=CC=CN=C1F FIDJLNBSSLXRLL-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011508745A JP5638515B2 (ja) | 2008-08-27 | 2009-08-26 | ピロール化合物 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008218851 | 2008-08-27 | ||
| JP2008218851 | 2008-08-27 | ||
| JP2008269099 | 2008-10-17 | ||
| JP2008269099 | 2008-10-17 | ||
| PCT/JP2009/065279 WO2010024451A1 (en) | 2008-08-27 | 2009-08-26 | Pyrrole compounds |
| JP2011508745A JP5638515B2 (ja) | 2008-08-27 | 2009-08-26 | ピロール化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012501296A JP2012501296A (ja) | 2012-01-19 |
| JP2012501296A5 true JP2012501296A5 (OSRAM) | 2012-09-13 |
| JP5638515B2 JP5638515B2 (ja) | 2014-12-10 |
Family
ID=41508823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508745A Active JP5638515B2 (ja) | 2008-08-27 | 2009-08-26 | ピロール化合物 |
Country Status (38)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2318390T3 (pl) | 2008-08-27 | 2013-09-30 | Takeda Pharmaceuticals Co | Związki pirolowe |
| US20110229879A1 (en) * | 2010-03-19 | 2011-09-22 | University Of Rochester | Methods and compositions for nuclear staining |
| CN102452979B (zh) * | 2010-11-03 | 2015-04-01 | 天津药明康德新药开发有限公司 | 5-氟-3-吡啶磺酰氯的合成方法 |
| CN102863371B (zh) * | 2011-07-06 | 2016-04-13 | 中国科学院上海有机化学研究所 | 氟代二氢吡咯或氟代吡咯 |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| CN110917130A (zh) | 2012-06-27 | 2020-03-27 | 武田药品工业株式会社 | 用盐稳定的胺和有机酸的液体制剂 |
| WO2014133059A1 (ja) * | 2013-02-28 | 2014-09-04 | 武田薬品工業株式会社 | スルホニルクロライド化合物の製造法 |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| KR102084185B1 (ko) | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
| CN105367550A (zh) * | 2014-08-11 | 2016-03-02 | 江苏柯菲平医药股份有限公司 | 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用 |
| UY36547A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| TWI710379B (zh) | 2015-07-30 | 2020-11-21 | 日商武田藥品工業股份有限公司 | 錠劑 |
| ES2882667T3 (es) | 2015-08-07 | 2021-12-02 | Bayer Cropscience Ag | Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas |
| CN106430006B (zh) * | 2016-08-18 | 2018-06-12 | 国网湖南省电力公司带电作业中心 | 配电线路移动式绝缘登高作业装置及方法 |
| CN108203430A (zh) * | 2016-12-16 | 2018-06-26 | 天地人和生物科技有限公司 | 一种新型可逆性质子泵抑制剂及其制备方法和用途 |
| PE20200442A1 (es) | 2017-07-10 | 2020-02-28 | Takeda Pharmaceuticals Co | Preparacion que comprende vonoprazan |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| CN113527536B (zh) * | 2020-04-21 | 2024-03-22 | 杭州德柯医疗科技有限公司 | 一种含氟多糖高分子化合物及其制备方法 |
| ES3014815T3 (en) * | 2020-06-17 | 2025-04-25 | Ildong Pharmaceutical Co Ltd | Novel acid secretion inhibitor and use thereof |
| EP4074317A1 (en) | 2021-04-14 | 2022-10-19 | Bayer AG | Phosphorus derivatives as novel sos1 inhibitors |
| CN113620930B (zh) * | 2021-07-12 | 2022-08-16 | 南京烁慧医药科技有限公司 | 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用 |
| KR20240119083A (ko) * | 2021-12-15 | 2024-08-06 | 일동제약(주) | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR102802551B1 (ko) * | 2021-12-15 | 2025-05-07 | 유노비아 주식회사 | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20230102353A (ko) * | 2021-12-30 | 2023-07-07 | 주식회사 대웅제약 | 삼중음성유방암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3772301D1 (de) | 1986-08-29 | 1991-09-26 | Pfizer | 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren. |
| US5128366A (en) | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
| AU8653891A (en) | 1990-08-31 | 1992-03-30 | Warner-Lambert Company | Amino acid analogs as cck antagonists |
| US5331006A (en) | 1990-08-31 | 1994-07-19 | Warner-Lambert Company | Amino acid analogs as CCK antagonists |
| CZ290470B6 (cs) | 1991-10-18 | 2002-07-17 | Monsanto Technology Llc | 5 či 6 členné aromáty jako fungicidy pro kontrolu stéblolamu rostlin, způsob kontroly a fungicidní směs k provedení tohoto způsobu |
| CN1071924A (zh) | 1991-10-29 | 1993-05-12 | 纳幕尔杜邦公司 | 除草的三唑羧酸酰胺 |
| JPH06135961A (ja) | 1992-10-23 | 1994-05-17 | Nippon Iyakuhin Kogyo Kk | 新規ジフェニルピロリルフラン誘導体 |
| US5286742A (en) | 1992-11-03 | 1994-02-15 | American Cyanamid Company | Pyrrole thiocarboxamide insecticidal and acaricidal agents |
| US5480902A (en) | 1993-08-31 | 1996-01-02 | American Cyanamid Company | Thienylpyrrole fungicidal agents |
| JPH08119936A (ja) | 1994-10-18 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | 複素環式誘導体 |
| JPH0930967A (ja) | 1995-07-17 | 1997-02-04 | Chugai Pharmaceut Co Ltd | 抗潰瘍剤 |
| JP3541043B2 (ja) | 1996-08-28 | 2004-07-07 | ザ プロクター アンド ギャンブル カンパニー | 置換環状アミンメタロプロテアーゼ阻害剤 |
| WO1998028269A1 (en) | 1996-12-23 | 1998-07-02 | Du Pont Pharmaceuticals Company | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| JPH11209344A (ja) | 1998-01-26 | 1999-08-03 | Kyowa Hakko Kogyo Co Ltd | 含窒素複素環化合物 |
| GB9817548D0 (en) | 1998-08-12 | 1998-10-07 | Novartis Ag | Organic compounds |
| JP3828364B2 (ja) | 1999-03-10 | 2006-10-04 | 塩野義製薬株式会社 | ［２．２．１］および［３．１．１］ビシクロ骨格を有するｐｇｄ２／ｔｘａ２両受容体拮抗性医薬組成物 |
| TW575561B (en) | 1999-03-25 | 2004-02-11 | Hoffmann La Roche | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives |
| AU3783100A (en) | 1999-06-14 | 2000-12-21 | Dow Agrosciences Llc | Substituted triazoles, imidazoles and pyrazoles as herbicides |
| IL148084A0 (en) | 1999-08-26 | 2002-09-12 | Aventis Pharm Prod Inc | Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| AU2001258784A1 (en) | 2000-05-22 | 2001-12-03 | Takeda Chemical Industries Ltd. | Tyrosine phosphatase inhibitors |
| US6589978B2 (en) | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| GB0016453D0 (en) | 2000-07-04 | 2000-08-23 | Hoffmann La Roche | Pyrrole derivatives |
| CN1582281A (zh) | 2001-10-01 | 2005-02-16 | 大正制药株式会社 | Mch受体拮抗剂 |
| CA2466375A1 (en) | 2001-11-08 | 2003-05-15 | Pharmacia & Upjohn Company | Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| US20050014954A1 (en) | 2001-11-22 | 2005-01-20 | Reinhold Ohrlein | Pyrrole synthesis |
| US20050101657A1 (en) | 2001-12-28 | 2005-05-12 | Takeda Chemical Industries Ltd. | Androgen receptor antagonists |
| AU2003216274A1 (en) | 2002-02-11 | 2003-09-04 | Neurocrine Biosciences, Inc. | Pyrrole derivatives as ligands of melanocortin receptors |
| WO2003068740A1 (en) | 2002-02-14 | 2003-08-21 | Wyeth | Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| TW200306191A (en) | 2002-02-22 | 2003-11-16 | Teijin Ltd | Pyrrolopyrimidine derivatives |
| AU2003245464A1 (en) | 2002-06-13 | 2003-12-31 | E.I. Du Pont De Nemours And Company | Pyrazole and pyrrole carboxamide insecticides |
| CA2495216A1 (en) | 2002-08-12 | 2004-02-19 | Sugen, Inc. | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| JP2004315511A (ja) | 2003-03-31 | 2004-11-11 | Taisho Pharmaceut Co Ltd | Ｍｃｈ受容体アンタゴニスト |
| ES2351393T3 (es) | 2003-05-26 | 2011-02-03 | Takeda Pharmaceutical Company Limited | Sulfopirroles. |
| KR101178747B1 (ko) | 2004-09-30 | 2012-09-03 | 다케다 야쿠힌 고교 가부시키가이샤 | 프로톤 펌프 저해제 |
| EP1655284A1 (en) | 2004-10-26 | 2006-05-10 | Aponetics AG | 2-Phenylsulfopyrroles |
| CA2621182C (en) * | 2005-08-30 | 2014-03-18 | Takeda Pharmaceutical Company Limited | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| US8512761B2 (en) | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
| WO2007114338A1 (ja) | 2006-03-31 | 2007-10-11 | Takeda Pharmaceutical Company Limited | 酸分泌抑制薬 |
| US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| TW200920366A (en) | 2007-09-28 | 2009-05-16 | Takeda Pharmaceutical | 5-membered heterocyclic compound |
| US20090318429A1 (en) | 2008-04-28 | 2009-12-24 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives |
| WO2009140624A2 (en) | 2008-05-16 | 2009-11-19 | Takeda San Diego, Inc. | Glucokinase activators |
| PL2318390T3 (pl) | 2008-08-27 | 2013-09-30 | Takeda Pharmaceuticals Co | Związki pirolowe |
-
2009
- 2009-08-26 PL PL09788053T patent/PL2318390T3/pl unknown
- 2009-08-26 UA UAA201103600A patent/UA105185C2/uk unknown
- 2009-08-26 JO JO2009322A patent/JO2871B1/en active
- 2009-08-26 BR BRPI0917705A patent/BRPI0917705A2/pt not_active IP Right Cessation
- 2009-08-26 PT PT97880538T patent/PT2318390E/pt unknown
- 2009-08-26 CA CA2735162A patent/CA2735162C/en not_active Expired - Fee Related
- 2009-08-26 EP EP09788053.8A patent/EP2318390B1/en active Active
- 2009-08-26 EA EA201170384A patent/EA019741B1/ru not_active IP Right Cessation
- 2009-08-26 ME MEP-2013-90A patent/ME01598B/me unknown
- 2009-08-26 US US13/061,078 patent/US8592597B2/en active Active
- 2009-08-26 US US12/547,778 patent/US8969387B2/en active Active
- 2009-08-26 JP JP2011508745A patent/JP5638515B2/ja active Active
- 2009-08-26 NZ NZ591793A patent/NZ591793A/xx not_active IP Right Cessation
- 2009-08-26 HR HRP20130653AT patent/HRP20130653T1/hr unknown
- 2009-08-26 PE PE2011000194A patent/PE20110300A1/es not_active Application Discontinuation
- 2009-08-26 AR ARP090103278A patent/AR073136A1/es unknown
- 2009-08-26 RS RS20130319A patent/RS52872B/sr unknown
- 2009-08-26 AU AU2009284867A patent/AU2009284867B2/en not_active Ceased
- 2009-08-26 UY UY0001032074A patent/UY32074A/es not_active Application Discontinuation
- 2009-08-26 DK DK09788053.8T patent/DK2318390T3/da active
- 2009-08-26 MX MX2011001955A patent/MX2011001955A/es active IP Right Grant
- 2009-08-26 WO PCT/JP2009/065279 patent/WO2010024451A1/en not_active Ceased
- 2009-08-26 KR KR1020117006779A patent/KR101629181B1/ko active Active
- 2009-08-26 MY MYPI20110861 patent/MY152008A/en unknown
- 2009-08-26 TW TW98128638A patent/TWI473798B/zh not_active IP Right Cessation
- 2009-08-26 CN CN200980142371.0A patent/CN102197033B/zh active Active
- 2009-08-26 ES ES09788053T patent/ES2423289T3/es active Active
- 2009-08-26 PE PE2013002359A patent/PE20141174A1/es not_active Application Discontinuation
- 2009-08-26 SI SI200930654T patent/SI2318390T1/sl unknown
- 2009-08-26 GE GEAP200912153A patent/GEP20135786B/en unknown
-
2011
- 2011-02-21 IL IL211335A patent/IL211335A/en not_active IP Right Cessation
- 2011-02-24 CL CL2011000402A patent/CL2011000402A1/es unknown
- 2011-02-25 DO DO2011000061A patent/DOP2011000061A/es unknown
- 2011-03-08 ZA ZA2011/01774A patent/ZA201101774B/en unknown
- 2011-03-18 MA MA33715A patent/MA32647B1/fr unknown
- 2011-03-25 CR CR20110169A patent/CR20110169A/es unknown
- 2011-03-25 CO CO11036583A patent/CO6321166A2/es active IP Right Grant
- 2011-03-25 EC EC2011010912A patent/ECSP11010912A/es unknown
-
2013
- 2013-07-26 CY CY20131100636T patent/CY1114452T1/el unknown
- 2013-07-26 SM SM201300085T patent/SMT201300085B/xx unknown
- 2013-10-01 US US14/043,018 patent/US8993598B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501296A5 (OSRAM) | ||
| JP5315254B2 (ja) | 溶媒和物化されたイラプラゾールの結晶形 | |
| JP5638515B2 (ja) | ピロール化合物 | |
| JPWO2012102255A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| KR101777971B1 (ko) | 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도 | |
| JP2011518173A5 (OSRAM) | ||
| JPWO2012102254A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JP2009520765A5 (OSRAM) | ||
| JP2016512823A5 (OSRAM) | ||
| WO2007114338A1 (ja) | 酸分泌抑制薬 | |
| JP5653842B2 (ja) | レニン阻害剤としての３，４−置換ピペリジン誘導体 | |
| JP3741120B2 (ja) | Ｎ−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法 | |
| WO2011013624A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JP2011520924A (ja) | レニン阻害剤としての３，４−置換ピペリジン誘導体 | |
| HUT64320A (en) | Process for production antiallergic imidazole derivatives and pharmaceutical preparations containing these compounds | |
| JP5575357B2 (ja) | 組織因子産生抑制剤 | |
| JPWO2006022374A1 (ja) | ２−フェニルピリジン誘導体 | |
| DK2207776T3 (en) | Drug active in neuropathic pain | |
| TWI327144B (en) | 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives | |
| JP7252978B2 (ja) | ２－（１－（ｔｅｒｔ－ブトキシカルボニル）ピペリジン－４－イル）安息香酸を調製するためのプロセス | |
| JP2014518236A (ja) | ６−（ピペリジン−４−イルオキシ）−２ｈ−イソキノリン−１−オン塩酸塩の多形体 | |
| JP4898287B2 (ja) | ［１−［２−［４−［ｎ−（５−メチルピリジン−２−イル）−２−フランカルボキサミド］ピペリジン−１−イル］エチル］シクロヘキシル］アセトヒドロキサム酸の製造方法 |